These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma bilirubin and late graft failure in renal transplant recipients. Deetman PE; Zelle DM; Homan van der Heide JJ; Navis GJ; Gans RO; Bakker SJ Transpl Int; 2012 Aug; 25(8):876-81. PubMed ID: 22716194 [TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. Nafar M; Sahraei Z; Salamzadeh J; Samavat S; Vaziri ND Iran J Kidney Dis; 2011 Nov; 5(6):357-72. PubMed ID: 22057066 [TBL] [Abstract][Full Text] [Related]
4. Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome? Kundur AR; Singh I; Bulmer AC Atherosclerosis; 2015 Mar; 239(1):73-84. PubMed ID: 25576848 [TBL] [Abstract][Full Text] [Related]
5. Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury. Kim JY; Lee DY; Kang S; Miao W; Kim H; Lee Y; Jon S Biomaterials; 2017 Jul; 133():1-10. PubMed ID: 28414974 [TBL] [Abstract][Full Text] [Related]
6. Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study. McDonald GB; Evans AT; McCune JS; Schoch G; Ostrow JD; Gooley TA Lancet Haematol; 2016 Nov; 3(11):e516-e525. PubMed ID: 27968820 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications of bilirubin and biliverdin in transplantation. Ollinger R; Wang H; Yamashita K; Wegiel B; Thomas M; Margreiter R; Bach FH Antioxid Redox Signal; 2007 Dec; 9(12):2175-85. PubMed ID: 17919067 [TBL] [Abstract][Full Text] [Related]
8. Potential benefits of melatonin in organ transplantation: a review. Esteban-Zubero E; García-Gil FA; López-Pingarrón L; Alatorre-Jiménez MA; Iñigo-Gil P; Tan DX; García JJ; Reiter RJ J Endocrinol; 2016 Jun; 229(3):R129-46. PubMed ID: 27068700 [TBL] [Abstract][Full Text] [Related]
11. Prolonged ischemia elicits acute allograft rejection involved in CXCR3 activation in rat kidney transplants. Zou XF; Song B; Duan JH; Hu ZD; Cui ZL; Gu C Transpl Immunol; 2015 Oct; 33(2):103-9. PubMed ID: 26303820 [TBL] [Abstract][Full Text] [Related]
12. Etiology and incidence of unconjugated hyperbilirubinemia after orthotopic liver transplantation. Gates LK; Wiesner RH; Krom RA; Steers J; Gores GJ; Hay JE; Porayko MK Am J Gastroenterol; 1994 Sep; 89(9):1541-3. PubMed ID: 8079934 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial. Sun Q; Hong L; Huang Z; Na N; Hua X; Peng Y; Zhao M; Cao R; Sun Q Trials; 2017 Nov; 18(1):545. PubMed ID: 29145879 [TBL] [Abstract][Full Text] [Related]
14. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients. Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032 [TBL] [Abstract][Full Text] [Related]